Trial site
National University Hospital Singapore
- 14running trials
- 5closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Hepatitis B2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Alzheimer disease1 trial
- Cerebral palsy1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Depression1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Hepatitis C1 trial
- High blood pressure1 trial
- and 6 more
- Phase
- Phase 27 trials
- Phase 33 trials
- Phase 1/22 trials
- Phase 11 trial
- Status
- Recruiting7 trials
- Completed5 trials
- Active, not recruiting4 trials
- Not yet recruiting3 trials
- Lead sponsor
- National University Hospital, Singapore4 trials
- National Cancer Institute (NCI)2 trials
- AusperBio Therapeutics Inc.1 trial
- BeOne Medicines1 trial
- Chinese University of Hong Kong1 trial
- and 10 more
Running trials
Not yet recruiting
Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment
Not yet recruiting
Recruiting
Recruiting
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
Recruiting
Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
Active, not recruiting
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Cerebral palsy1 recruiting
- Depression1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Hepatitis B1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Liver cirrhosis1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone
Completed
Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction
Site data: ClinicalTrials.govUpdated 17 Nov 2026